Study of Juvenile Idiopathic Arthritis in Children
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study looks at children with arthritis to better understand their condition using clinical exams, lab tests, and ultrasounds. It may help doctors learn more about different types of juvenile arthritis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be under 18 years old.
- You must have had joint swelling or pain for at least 6 weeks with no known cause.
- Your parent or guardian must agree to let you take part in the study.
- You cannot have a type of juvenile arthritis that affects your whole body (systemic onset).
- You cannot have arthritis that started because of another condition like inflammatory bowel disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children and young adults newly diagnosed with certain types of arthritis or related conditions to learn more about their health over time. It may help doctors better understand how these diseases progress and how treatments work.
This study looks at pain in kids with juvenile arthritis compared to healthy kids. It may help researchers understand pain better and improve future treatments.
This study looks at how certain blood markers relate to disease activity in children with juvenile idiopathic arthritis (JIA). It aims to help doctors better understand and track the condition, which could lead to improved care.
This trial tests whether a special diet can help children and teens with juvenile arthritis. If you join, you will follow the diet and provide stool samples so the researchers can see how it affects your gut and arthritis.
This study creates a personalized medicine network to better understand and treat childhood arthritis. If you have JIA or unexplained joint inflammation, researchers will look at your biology to find the best treatment approach for you.
This study looks at specific white blood cells (lymphocytes) in people with juvenile idiopathic arthritis (JIA) whose disease is inactive. It aims to understand how these cells differ based on the type of JIA and the medications used.
Hear when a new Juvenile Idiopathic Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.